Market Overview 2022-2027
IMARC Group has recently released a new research study “Male Infertility Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What are the growth prospects of the Male Infertility Industry?
The global male infertility market size reached US$ 3.55 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.97 Billion by 2027, exhibiting a growth rate (CAGR) of 5.60% during 2022-2027.
Impact of COVID-19:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request For Sample Report https://www.imarcgroup.com/male-infertility-market/requestsample
What is a Male Infertility Market?
Male infertility represents a disease of the reproductive system that lowers the chance of the affected individual to impregnate a fertile woman. It can occur, owing to blockages, abnormal sperm function, and low sperm production that prevents the delivery of sperm. Some factors that may contribute to male infertility include genetic defects, undescended testicles, sperm illnesses, injuries, diabetes, or infections, such as chlamydia, gonorrhea, mumps, HIV, etc. It can be treated by vasoepididymostomy, hormone therapy, and assisted reproductive technology (ART) procedures, including in vitro fertilization (IVF) and varicocele surgery. These procedures aid in enhancing the reproductive health of males, restoring testosterone levels, and improving the quality of sperm to enable pregnancy.
What are the major market drivers in the Male Infertility Market ?
The growing incidences of chronic diseases, such as diabetes, obesity, hypertension, etc., on account of sedentary lifestyles and lack of physical activities, are primarily driving the male infertility market. Additionally, the escalating demand for ART procedures, such as IVF, that involve the adoption of previously frozen sperms is further catalyzing the market growth.
Besides this, the rising utilization of deoxyribonucleic acid (DNA) fragmentation techniques and computer-assisted semen analysis to diagnose hypospermia, measure semen volume, and determine male infertility is acting as another significant growth-inducing factor.
Moreover, the easy availability of several infertility treatment drugs, procedures, devices, etc., the increasing workload and the accompanying stress, and unhealthy habits, such as excessive consumption of drugs, alcohol, smoking, etc., are also positively influencing the global market. Apart from this, the launch of various favorable policies by government bodies for improving reimbursement scenarios for infertility-related treatments and enhancing the safety of patient data is propelling the market growth. Furthermore, extensive R&D activities are anticipated to fuel the male infertility market over the forecasted period.
|Male Infertility Market Report Scope|
|Market size value in 2021||US$ 3.55 Billion|
|Market forecast in 2027||US$ 4.97 Billion|
|Growth Rate||CAGR of 5.60% from 2022 to 2027|
|Base year for estimation||2021|
|Report coverage||Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends|
|Segments covered||Test Type, Treatment, Distribution Channel and End User|
|Regional scope||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Key companies profiled||Andrology Solutions, CinnaGen Co., Halotech DNA, SCSA Diagnostics Inc., Vitrolife, Zydus Lifesciences Limited, Intas Pharmaceuticals Ltd. and Endo International plc.|
|Market Dynamics||Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,|
|Customization purview||If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.|
Click here to view detailed information with table of content: https://www.imarcgroup.com/male-infertility-market
Breakup by Test Type:
- Sperm Agglutination
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Computer Assisted Semen Analysis
- Sperm Penetration Assay
Breakup by Treatment:
- Assisted Reproductive Technology and Varicocele Surgery
Breakup by Distribution Channel:
- Hospitals Pharmacies
- Pharmacies and Drug Stores
- Online Pharmacies
Breakup by End User:
- Hospitals and Clinics
- Fertility Centers
- Research Institutes
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
List of Major Key Players:
The major players in the market are
Halotech DNA, SCSA Diagnostics Inc.
Vitrolife, Zydus Lifesciences Limited
Intas Pharmaceuticals Ltd.
and Endo International plc.
Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800